Atlas Trials

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Clinical trial NCT01617460 · COMPLETED

Trial details

NCT number
NCT01617460
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Autistic Disorder
Start date
2012-09-01
Primary completion
2016-10-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.